Cytophage Technologies (TSXV:CYTO.H) Total Receivables: C$0.28 Mil (As of Dec. 2025)


What is Cytophage Technologies Total Receivables?

Cytophage Technologies TSXV:CYTO.H Total Receivables is C$0.28 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Cytophage Technologies's Total Receivables for the quarter that ended in Dec. 2025 was C$0.28 Mil.

Cytophage Technologies Total Receivables Related Terms

Cytophage Technologies Total Receivables Historical Data

* Premium members only.

The historical data trend for Cytophage Technologies's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cytophage Technologies Total Receivables Chart

Cytophage Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
0.10 0.20 0.35 0.20 0.28

Cytophage Technologies Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.10 0.09 0.12 0.28

Cytophage Technologies Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of C$0.28 Mil mean?
Cytophage Technologies (TSXV:CYTO.H) has a Total Receivables of C$0.28 Mil as of Dec. 2025. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Cytophage Technologies and its competitors.
Is Cytophage Technologies' Total Receivables too high?
Cytophage Technologies' current Total Receivables is C$0.28 Mil.
How does Cytophage Technologies' Total Receivables compare to VRTX and REGN?
Cytophage Technologies' Total Receivables of C$0.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Biotechnology company?
A good Total Receivables depends on the Biotechnology industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Cytophage Technologies and its competitors. Cytophage Technologies's current Total Receivables is C$0.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cytophage Technologies stock overvalued right now?
Cytophage Technologies (TSXV:CYTO.H) has a current Total Receivables of C$0.28 Mil. The current Total Receivables is C$0.28 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Cytophage Technologies (TSXV:CYTO.H), the current Total Receivables is C$0.28 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cytophage Technologies Business Description

Address 400 Fort Whyte Way, Suite 200A, Oak Bluff, MB, CAN, R4G 0B1
Cytophage Technologies Ltd is a Canadian biotechnology company engaged in the development of bacteriophages using molecular genetics and synthetic biology techniques. The company focuses on developing bacteriophage-based solutions to address bacterial challenges affecting animal health, human health, and food security, including antibiotic-resistant bacterial strains.